Enicar Pharmaceuticals Private Limited, a active private limited company, was established on 06 July 1994 in Boisar, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1994PTC079450. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.90 M.
It upholds a compliant status. Employing 222 professional, Its leadership includes Milind Balwant Save (Director), Sharmila Milind Save (Director), Swarali Milind Save (Director). Past directors included Rajendra Ratilal Chavhan, Balwant Moreshwar Save. It holds ₹22.66 Cr open charges and ₹24.64 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at J-214/215,Midc Tarapur Boisar ,Taluka-Palghar, Boisar, Maharashtra, 401506.
U24230MH1994PTC079450
079450
06 July 1994
₹2.50 M
₹0.90 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Enicar Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Milind Balwant Save | Director | 06 Jul 1994 | Current |
| Sharmila Milind Save | Director | 06 Jul 1994 | Current |
| Swarali Milind Save | Director | 05 Oct 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Mar 2014 | Past |
| Pramod Abcsdd | Director | 09 Apr 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enicar Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 8.14% increase. The company also saw a slight improvement in profitability, with a 4.83% increase in profit. The company's net worth Soared by an impressive increase of 20.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Enicar Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹226,635,000.00
₹246,382,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Aug 2020 | Axis Bank Limited | ₹3.54 Cr | Open |
| 29 Jan 2018 | Axis Bank Limited | ₹19.08 Cr | Open |
| 11 Dec 2003 | The Saraswat Co-Operative Bank Ltd. | ₹0.44 M | Open |
| 16 Oct 2017 | Others | ₹10.00 Cr | Satisfied |
| 12 Jul 2017 | Others | ₹6.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Enicar Pharmaceuticals has a workforce of 222 employees as of Mar 06, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Enicar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enicar Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Enicar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Enicar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge with Axis Bank Limited of Rs. 190.80 M registered on 29 Jan 2018 with Charge ID 100154814 was modified on 19 Mar 2024. was recorded as a recent event.
A charge with Axis Bank Limited of Rs. 35.40 M registered on 19 Aug 2020 with Charge ID 100372178 was modified on 25 Jan 2022. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 35.40 M with Charge ID 100372178 was registered on 19 Aug 2020. was recorded as a recent event.
The activity A charge registered on 23 Apr 2015 via Charge ID 10584896 with Vasai Vikas Sahakari Bank Limited was fully satisfied on 16 Feb 2018. was completed.
The CIN of Enicar Pharmaceuticals Private Limited is U24230MH1994PTC079450.
Enicar Pharmaceuticals Private Limited is headquartered at J-214/215,Midc Tarapur Boisar ,Taluka-Palghar, Boisar, Maharashtra, 401506.
Enicar Pharmaceuticals Private Limited was incorporated on 06 July 1994.
The current directors of Enicar Pharmaceuticals Private Limited are
The primary industry of Enicar Pharmaceuticals Private Limited is Manufacturing.
Enicar Pharmaceuticals Private Limited is unlisted.
The authorized capital of Enicar Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹0.90 M.
The compliance status of Enicar Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX